by Sue Brown, CEO ARMA
The majority of people with an MSK condition will rarely, if ever, need secondary care for that condition. All of them will need primary and community care. This is where people access MSK rehab, self-management support and a wide variety of treatment. Yet the main focus of the NHS remains hospitals. It’s what politicians talk about, what the media covers and where the majority of the attention of local systems focuses.
The King’s Fund has just published a report, Making Care Closer to Home a Reality, outlining why this problem occurs and some possible solutions.…
Read more of this article
Join the monthly NRAS Live on Wednesday 28th February. This month, Clare will be in discussion with Professor James Galloway, who will be presenting 5 years of the National Early Inflammatory Arthritis Audit (NEIAA). James is the Analytics Lead for the NEIAA and an Academic Rheumatologist, Senior Lecturer at King’s College London. There will be a panel discussion as to what five years of data gathering has brought to light, what’s changed over the years and how such national audits drive improvements in patient care.…
In what is very likely to be an election year, National Voices have shared their Manifesto for Equitable Healthcare – which puts forth three general election priorities.
The latest Airing Pain Podcast, Societal Inequalities and Disparities in Pain Management, is available now.
New white paper on environmental sustainability in orthopaedic surgery & MSK Health
The Society of Musculoskeletal Medicine (SOMM) has been very fortunate to have Karen Middleton, recently retired as CEO of the Chartered Society of Physiotherapy, as its President for many years and we thank her for her valuable contribution to SOMM and wish her well as she retires from that role as well.